Evidence map›Paper›PMID 25767086›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2016

Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads.

Amit Noheria, Shiva P Ponamgi, Christopher V Desimone, Vaibhav R Vaidya, Christopher A Aakre, Elisa Ebrille, Tiffany Hu, David O Hodge, Joshua P Slusser, Naser M Ammash and 4 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Infectious mass debulking in lead-associated endocarditis with a percutaneous aspiration system.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Observational
  3. A Rare Cause of Pulmonary Embolism: Lead Fracture in an Unexpected Area.Journal of clinical practice and research · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Idiopathic late coronary sinus lead dislodgement presenting with pulmonary embolism.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2016
    Article
  15. Considerations for cardiac device lead extraction.Nature reviews. Cardiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Amit NoheriaDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Shiva P PonamgiDivision of Hospital Internal Medicine, Mayo Clinic Health System, Austin, MN, USA.
Christopher V DesimoneDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Vaibhav R VaidyaDivision of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Christopher A AakreDivision of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Elisa EbrilleDivision of Cardiology, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Tiffany HuMayo Medical School, Rochester, MN, USA.
David O HodgeDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Joshua P SlusserDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Naser M AmmashDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Charles J BruceDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Alejandro A RabinsteinDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Paul A FriedmanDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Samuel J AsirvathamDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA asirvatham.samuel@mayo.edu.
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USMayo Clinic Health System · USUniversity of Turin · IT

Funding

CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
NHLBI NIH HHS HL007111NHLBI NIH HHS T32 HL007111
6 · The paper itself

Abstract

backgroundCardiac implantable electronic devices (CIEDs) are commonly associated with transvenous lead-related thrombi that can cause pulmonary embolism (PE). METHODS AND

resultsWe retrospectively evaluated all patients with transvenous CIED leads implanted at Mayo Clinic Rochester between 1 January 2000, and 25 October 2010. Pulmonary embolism outcomes during follow-up were screened using diagnosis codes and confirmed with imaging study reports. Of 5646 CIED patients (age 67.3 ± 16.3 years, 64% men, mean follow-up 4.69 years) 88 developed PE (1.6%), incidence 3.32 [95% confidence interval (CI) 2.68-4.07] per 1000 person-years [men: 3.04 (95% CI 2.29-3.96) per 1000 person-years; women: 3.81 (95% CI 2.72-5.20) per 1000 person-years]. Other than transvenous CIED lead(s), 84% had another established risk factor for PE such as deep vein thrombosis (28%), recent surgery (27%), malignancy (25%), or prior history of venous thromboembolism (15%). At the time of PE, 22% had been hospitalized for ≥ 48 h, and 59% had been hospitalized in the preceding 30 days. Pulmonary embolism occurred in 22% despite being on systemic anticoagulation therapy. Out of 88 patients with PE, 45 subsequently died, mortality rate 93 (95% CI 67-123) per 1000 person-years (hazard ratio 2.0, 95% CI 1.5-2.7, P < 0.0001).

conclusionsThough lead-related thrombus is commonly seen in patients with transvenous CIED leads, clinical PE occurs with a low incidence. It is possible that embolism of lead thrombus is uncommon or emboli are too small to cause consequential pulmonary infarction.

Indexed as

AdolescentAdultAgedAged, 80 and overArrhythmias, CardiacChildChild, PreschoolDefibrillators, ImplantableFemaleHumansIncidenceInfantInfant, NewbornKaplan-Meier EstimateMaleMiddle AgedAndexanet alfaCIEDCiraparantagDefibrillatorEpidemiologyICDIdarucizumabPacemakerPulmonary embolism

Identifiers

PMID25767086
PMCPMC4767120
OpenAlexW1998580799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.